Istopril (Enalapril Maleate)

Enalapril is converted to enalaprilat, which blocks the angiotensin‑converting enzyme. This prevents formation of angiotensin II, leading to vasodilation, reduced aldosterone release, lower sodium and water retention, and ultimately decreased blood pressure and cardiac workload.

The appropriate dose of Istopril is determined by the prescribing clinician based on the patient’s condition, response, and renal function. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Istopril is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be avoided during pregnancy. Limited data are available for breastfeeding; the drug may pass into milk, so use is generally not recommended without medical advice.

To order Istopril, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Istopril (enalapril) shares the same mechanism as other ACE inhibitors such as lisinopril or ramipril. Clinical efficacy and safety profiles are comparable, though individual patient response, dosing frequency, and tolerability may differ, making prescriber choice dependent on specific patient factors.

Istopril tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Istopril is taken orally, usually once or twice daily as directed by a healthcare professional. Tablets should be swallowed whole with a glass of water and can be taken with or without food.

Serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension, acute kidney injury, and hyperkalemia. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden dizziness, or marked changes in urine output.

Istopril should not be used by patients with a known hypersensitivity to enalapril or any ACE inhibitor, those with a history of angioedema related to ACE inhibition, or pregnant women. Caution is advised in patients with severe renal impairment or bilateral renal artery stenosis.